From our Staff Correspondent
DIBRUGARH, September 4: The Regional Medical Research Centre (RMRC), North Eastern Region (NER), a premier Medical Research institute under the Indian Council of Medical Research (ICMR), Lahoal in Dibrugarh District has been recognized as an International Centre of Excellence by the National Institute of Health (NIH) and Washington University of USA recently.
The institute, fifth in the country, set up at Lahoal in Dibrugarh District mandated to look after the health research needs of the eight NE States has been marching ahead in scientific research and education under the stewardship of its Director, noted scientist, Dr Jagadish Mahanta.
Subsequent of this recognition, the NIH has funded a collaborative research project in RMRC, Lahoal for malaria. As a part of the project, the Director, RMRC, NER Dr J Mahanta, recently visited Guangzhou, People’s Republic of China to attend a conference on Evolution of Malaria in SE Asia from August 19 to August 23.
The institute, in collaboration with Centre for Development of Advance Computing (CDAC), Pune, has been awarded the “MoSQuIT – mBillionth SAARC Countries Award 2013” recognized by The Grand Jury of The mBillionth Award, South Asia as an Award Winner for the year 2013 for inventing disease surveillance system for malaria using mobile platform.
In response to the maiden Japanese encephalitis vaccine administered to adults in mass scale in Sivasagar, Assam, this centre undertook a study on “Evaluation of Safety and Immunogenicity of Single Dose of Live Attenuated Japanese Encephalitis Vaccine SA 14–14– 2 in Adults in Assam”. This study documented that the adult vaccination for JE prevention was highly effective as there was a fourfold rise to about 60 per cent level in immunogenicity in the population not exposed to JE virus earlier. The safety margin of this vaccine was found to be very high as no untoward effect was observed during the study.